Delayed emesis: moderately emetogenic chemotherapy

This publication has 23 references indexed in Scilit:

• Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions
  Supportive Care in Cancer, 2004
• Randomized, Double-Blind, Dose-Finding Study of Dexamethasone in Preventing Acute Emesis Induced by Anthracyclines, Carboplatin, or Cyclophosphamide:
  Journal of Clinical Oncology, 2004
• Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT₃ receptor antagonist
  Cancer, 2003
• Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan
  Supportive Care in Cancer, 2003
• Dexamethasone Alone or in Combination with Ondansetron for the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
  New England Journal of Medicine, 2000
• Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens
  Cancer Chemotherapy and Pharmacology, 1996
• Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy
  Annals of Oncology, 1996
• Prophylaxis of delayed nausea and vomiting after cancer chemotherapy
  The Netherlands Journal of Medicine, 1995
• Ondansetron Compared with Granisetron in the Prophylaxis of Cyclophosphamide-lnduced Emesis in Out-Patients: A Multicentre, Double-Blind, Double-Dummy, Randomised, Parallel-Group Study
  Oncology, 1995
• Ondansetron plus Metopimazine Compared with Ondansetron Alone in Patients Receiving Moderately Emetogenic Chemotherapy
  New England Journal of Medicine, 1993